-
公开(公告)号:WO2020022959A1
公开(公告)日:2020-01-30
申请号:PCT/SG2019/050354
申请日:2019-07-23
Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
Inventor: CHU, Justin Jang Hann , TEO, Fiona Mei Shan
IPC: G01N33/563
Abstract: The present invention relates to a method of detecting Hand-Foot-and-Mouth Disease (HFMD) in samples obtained from test subjects. In particular, the method relates to the detection of protein biomarkers in the saliva of these test subjects. In a preferred embodiment, the method comprising detecting in a saliva sample the presence and/or amount of at least one protein biomarker selected from the group consisting of PRX-IV, Legumain, SIL1 and CREG1, wherein the presence of the protein biomarker in the saliva is indicative of HFMD.
-
公开(公告)号:WO2019032054A1
公开(公告)日:2019-02-14
申请号:PCT/SG2018/050408
申请日:2018-08-13
Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
Inventor: WEE, Keng Boon
IPC: C12Q1/6813 , C12N15/113
Abstract: The present invention relates to a high-throughput method of screening splicing variants of target genes as drug targets or for characterisation of their biological functions. The disclosure provides a method for the screening of splicing variants, comprising: (a) providing a first antisense oligonucleotide capable of inducing a first splice event on the target gene to express a first splicing variant, and a second antisense oligonucleotide capable of inducing a second splice event on the target gene to express a second splicing variant; (b) hybridising the first and second antisense oligonucleotides to a pre-mRNA of the target gene; and (c) characterising the effect of the splice event. In one embodiment, the first antisense oligonucleotide switches the splice event that expresses the second splicing variant towards one that expresses the first splicing variant, while the second antisense oligonucleotide switches the splice event that expresses the first splicing variant towards one that expresses the second splicing variant.
-
公开(公告)号:WO2019022662A1
公开(公告)日:2019-01-31
申请号:PCT/SG2018/050362
申请日:2018-07-24
Inventor: VIRSHUP, David Marc , MADAN, Babita , WILLIAMS, Bart Owen
IPC: A61K31/663 , A61K31/497 , A61K31/522 , A61P17/02 , A61P19/08 , A61P35/00 , A61P43/00 , A61K9/00 , A61K38/00
CPC classification number: A61K31/663 , A61K9/0053 , A61K31/497 , A61K31/522 , A61K38/177 , A61K2300/00
Abstract: The invention concerns the use of a bisphosphonate to treat, mitigate or prevent the side effects associated with, or mediated by, the use of a Wnt secretion inhibitor to treat cancer or fibrosis; a method of treating, mitigating or preventing the side effects associated with, or mediated by, the use of a Wnt secretion inhibitor to treat cancer or fibrosis comprising the administration of a bisphosphonate; a combination therapeutic comprising a Wnt secretion inhibitor and a bisphosphonate; and a therapeutic treatment regimen comprising the use of a Wnt secretion inhibitor and a bisphosphonate.
-
公开(公告)号:WO2019004939A1
公开(公告)日:2019-01-03
申请号:PCT/SG2018/050313
申请日:2018-06-27
Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH , LION TCR
Inventor: GUCCIONE, Ernest , WEE, Keng Boon, Dave , BERTOLETTI, Antonio
IPC: C12N15/113 , C12N5/0783 , A61K31/7088 , A61K35/17 , A61P37/00 , A61P35/00 , A61P31/00
Abstract: The present invention relates to antisense oligonucleotides for modulating the function of a T cell, including antisense oligonucleotides that hybridise to IFN-γ, granzyme, perforin 1, PD-1, PRDM1, PD-L1, CD40LG, NDFIP1, PDCD1 LG2, REL, BTLA, CD80, CD160, CD244, LAG3, TIGIT, ADORA2A & TIM-3 RNAs. In particular, the present invention relates to antisense oligonucleotides capable of inducing exon skipping of RNA. Also claimed is a method for further modifying the specificity of said T-cell by providing for a T cell receptor gene.
-
公开(公告)号:WO2018194520A9
公开(公告)日:2018-10-25
申请号:PCT/SG2018/050194
申请日:2018-04-18
Inventor: LOBIE, Peter Edward , PANDEY, Vijay Kumar , KANCHUGARAKOPPAL SUBBEGOWDA, Rangappa , SALUNDI, Bassappa , CHAKRABHAVI DHANANJAYA, Mohan , RANGAPPA, Shobith , VENKATACHALAIAH, Srinivasa
IPC: C07D211/06 , C07D241/04 , A61K31/445 , A61K31/496 , A61P35/00
Abstract: The invention relates to compounds of general formula (I): wherein R 1 , n, R 2a , R 2b , and R 3 are as defined herein. The compounds are inhibitors of Bcl-2-associated death promoter (BAD) phosphorylation and have anti-apoptotic activity and are useful in the treatment of cancer, particularly breast cancer, endometrial cancer, ovarian cancer, liver cancer, colon cancer, prostate cancer or pancreatic cancer.
-
公开(公告)号:WO2018194520A1
公开(公告)日:2018-10-25
申请号:PCT/SG2018/050194
申请日:2018-04-18
Inventor: LOBIE, Peter Edward , PANDEY, Vijay Kumar , KANCHUGARAKOPPAL SUBBEGOWDA, Rangappa , SALUNDI, Bassappa , CHAKRABHAVI DHANANJAYA, Mohan , RANGAPPA, Shobith , VENKATACHALAIAH, Srinivasa
IPC: C07D211/06 , C07D241/04 , A61K31/445 , A61K31/496 , A61P35/00
Abstract: The invention relates to compounds of general formula (I): wherein R 1 , n, R 2a , R 2b , and R 3 are as defined herein. The compounds are inhibitors of Bcl-2-associated death promoter (BAD) phosphorylation and have anti-apoptotic activity and are useful in the treatment of cancer, particularly breast cancer, endometrial cancer, ovarian cancer, liver cancer, colon cancer, prostate cancer or pancreatic cancer.
-
公开(公告)号:WO2018174830A1
公开(公告)日:2018-09-27
申请号:PCT/SG2018/050134
申请日:2018-03-26
Inventor: CHU, Jang Hann, Justin , NYO, Min
IPC: C12Q1/6851 , A61K31/7088 , A61P31/14
Abstract: The present invention relates to a method of detecting Hand-Foot-and-Mouth Disease (HMFD) in subjects. In particular, the method relates to detecting promising biomarkers in the saliva of these subjects. In an aspect of the present invention, there is provided a method for detecting HFMD, the method comprising determining the presence of a microRNA (miRNA) in a saliva sample, wherein the presence of the miRNA in the saliva sample is indicative of HFMD. Preferably, the miRNA is any one selected from the group consisting of mir-18b, mir-125a, mir-145, mir-155, mir-221, mir-324, mir- 335 and further comprises mir-23a and mir-142.
-
公开(公告)号:WO2017200488A1
公开(公告)日:2017-11-23
申请号:PCT/SG2017/050258
申请日:2017-05-18
Applicant: IDEAL WORKSPACE PTE LTD
Inventor: DENG, Yuying , MCDONNELL, Andrew , BUTALIA, Siddartha , YANG, Thomas Zhong Ming
Abstract: A workstation apparatus for use on a flat surface, the workstation apparatus comprising: a base configured to be disposed on a support surface which is elevated from a floor surface; a fixed pillar attached to the base; a movable pillar movably attached to the fixed pillar; a work surface attached to the movable pillar; and a displacement mechanism configured to move the movable pillar between a lowered position and a raised position, a switch to control the displacement mechanism; at least one proximity sensor configured to detect an object and measure an object distance; and a control unit communicably coupled to the proximity sensor, configured to: determine a presence or absence of a user if a presence of the object and object motion are determined; and record a time stamp information and a position of the work surface; the workstation apparatus allowing a user to convert any elevated support surface like a desk to a sit-stand desk.
Abstract translation: 1。一种用于平坦表面的工作站装置,所述工作站装置包括:基座,所述基座被构造成布置在从地板表面升高的支撑表面上; 固定在基座上的支柱; 可移动的柱,其可移动地附接到所述固定柱; 附接到可移动柱的工作表面; 以及位移机构,该位移机构构造成使所述可移动柱在降低位置和升高位置之间移动,开关,用于控制所述位移机构; 至少一个接近传感器,被配置为检测物体并测量物体距离; 以及可通信地耦合到所述接近传感器的控制单元,所述控制单元被配置为:如果确定了所述对象和对象运动的存在,则确定用户的存在或不存在; 并记录时间戳信息和工作表面的位置; 工作站设备允许用户将任何高架支撑表面(如桌子)转换为坐立桌。 p>
-
公开(公告)号:WO2017196261A1
公开(公告)日:2017-11-16
申请号:PCT/SG2017/050248
申请日:2017-05-11
Applicant: NATIONAL UNIVERSITY OF SINGAPORE , ACADEMIA SINICA
Inventor: DYMOCK, Brian William , YANG, Eugene Guorong , YEN, Jong-Young , TAN, Eng Chong
IPC: C07D498/12 , A61K31/505 , A61P35/00 , A61P37/06
Abstract: The present disclosure described provides novel dual inhibition compounds that specifically target the JAK-STAT and HDAC pathways, two distinct cellular pathways that are useful in the treatment of various diseases and disorders. In certain aspects, the compounds described herein are useful in the treatment of cellular proliferative and inflammatory diseases or disorders, such as graft vs. host disease. In particular embodiments, the compounds described herein inhibit JAK2 and HDAC6.
Abstract translation: 所描述的本公开提供了特异性靶向JAK-STAT和HDAC途径的新型双重抑制化合物,两种不同的细胞途径可用于治疗各种疾病和病症。 在某些方面,本文所述的化合物可用于治疗细胞增殖性和炎性疾病或病症,例如移植物抗宿主病。 在具体的实施方案中,本文所述的化合物抑制JAK2和HDAC6。 p>
-
公开(公告)号:WO2017171654A1
公开(公告)日:2017-10-05
申请号:PCT/SG2017/050183
申请日:2017-03-31
Applicant: NATIONAL UNIVERSITY OF SINGAPORE
Inventor: PATZEL, Volker , PODDAR, Sushmita
Abstract: The invention concerns a trans-splicing RNA (tsRNA) molecule comprising one or multiple unstructured binding domains; a cell or vector comprising said tsRNA; and a method for killing cells or treating a disease using said tsRNA.
Abstract translation: 本发明涉及包含一个或多个非结构化结合结构域的反式剪接RNA(tsRNA)分子; 包含所述tsRNA的细胞或载体; 以及使用所述tsRNA杀死细胞或治疗疾病的方法。 p>
-
-
-
-
-
-
-
-
-